Skip to main content
. 2016 Jul 1;19(7):701–709. doi: 10.1089/jmf.2016.0010

Table 6.

List of ECM-Related Upregulated Genes in Skeletal Muscles Following Oral PVS Supplementation

Transcript cluster ID Gene symbol Gene description Fold change P
19015271 TNXB Tenascin XB 1.78 .0311
19011964 TNXB Tenascin XB 1.76 .0467
18807632 TNXB Tenascin XB 1.75 .0425
19018936 TNXB Tenascin XB 1.74 .0427
19012977 TNXB Tenascin XB 1.71 .0430
18907606 DCN Decorin 2.23 .0186
18907622 DCN Decorin 1.09 .0338
18874445 MYOF Myoferlin 1.11 .0207
18963453 COL1A1 Collagen, type I, alpha1 4.61 .0149
18811819 COL1A2 Collagen, type I, alpha2 5.13 .0076
18723098 COL3A1/MIR3606 Collagen, type III, alpha1/microRNA3606 5.18 .0086
18735673 COL5A2 Collagen, type V, alpha2 1.62 .0324
18738278 COL6A3 Collagen, type VI, alpha3 2.96 .0122
18830114 COL14A1 Collagen, type XIV, alpha1 2.07 .0061
18810809 ELN Elastin 1.13 .0187
18934479 FBN1 Fibrillin1 3.05 .0254
18737057 FN1 Fibronectin1 3.65 .0084

Data presented indicate fold change in expression of ECM-related genes following 8 weeks of oral PVS supplementation compared with corresponding baseline visits. Data correspond to Figure 1B (P < .05; FDR <5%).

ECM, extracellular matrix.